Heleen A. Crommelin

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Does luteal phase support in MOH-IUI treatment improve cumulative live birth rates in couples with unexplained subfertility? Study protocol of the LUMO study: a centre, randomised, double-blind, controlled trial with cost-effectiveness analysis.

Does luteal phase support in MOH-IUI treatment improve cumulative live birth rates in couples with unexplained subfertility? Study protocol of the LUMO study: a centre, randomised, double-blind, controlled trial with cost-effectiveness analysis.

Journal: BMJ open

Published: November 20, 2025

Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.

Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.

Journal: British journal of cancer

Published: June 13, 2025

Rationale and design of the HOVON 170 DLBCL-ANTICIPATE trial: preventing anthracycline-induced cardiac dysfunction with dexrazoxane.

Rationale and design of the HOVON 170 DLBCL-ANTICIPATE trial: preventing anthracycline-induced cardiac dysfunction with dexrazoxane.

Journal: Cardio-oncology (London, England)

Published: December 06, 2024

The effects of etidronate on brain calcifications in Fahr's disease or syndrome: rationale and design of the randomised, placebo-controlled, double-blind CALCIFADE trial.

The effects of etidronate on brain calcifications in Fahr's disease or syndrome: rationale and design of the randomised, placebo-controlled, double-blind CALCIFADE trial.

Journal: Orphanet journal of rare diseases

Published: April 21, 2023

Pharmacogenetics of antitumor necrosis factor therapy in severe sarcoidosis.

Pharmacogenetics of antitumor necrosis factor therapy in severe sarcoidosis.

Journal: Current opinion in pulmonary medicine

Published: March 25, 2020

Efficacy and safety of infliximab biosimilar Inflectra® in severe sarcoidosis.

Efficacy and safety of infliximab biosimilar Inflectra® in severe sarcoidosis.

Journal: Respiratory medicine

Published: November 24, 2017

Rhabdomyolysis in Clozapine Overdose.

Rhabdomyolysis in Clozapine Overdose.

Journal: Drug safety - case reports

Published: October 18, 2016

Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis.

Infliximab therapy balances regulatory T cells, tumour necrosis factor receptor 2 (TNFR2) expression and soluble TNFR2 in sarcoidosis.

Journal: Clinical and experimental immunology

Published: May 01, 2016

Can intermediate monocytes predict response to infliximab therapy in sarcoidosis?

Can intermediate monocytes predict response to infliximab therapy in sarcoidosis?

Journal: The European respiratory journal

Published: April 07, 2016

Managing FDG PET-positive sarcoidosis: "a riddle wrapped in a mystery inside an enigma".

Managing FDG PET-positive sarcoidosis: "a riddle wrapped in a mystery inside an enigma".

Journal: The European respiratory journal

Published: January 02, 2016

Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab.

Efficacy of adalimumab in sarcoidosis patients who developed intolerance to infliximab.

Journal: Respiratory medicine

Published: November 23, 2015

Is there evidence for anti-TNF drugs in joint involvement in sarcoidosis?

Is there evidence for anti-TNF drugs in joint involvement in sarcoidosis?

Journal: Immunotherapy

Published: June 23, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026